EEG Uses. Doctors use this test to diagnose epilepsy and other brain conditions, brain injuries, and sleep disorders.Seizures cause spikes on the EEG graph. Brain tumors or a stroke make the waves ...

Slow waves that usually only occur in the brain during sleep are also present during wakefulness in people with epilepsy and may protect against increased brain excitability associated with the ...

SAN DIEGO, Dec. 6, 2022 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX), a leading neuroscience-focused biopharmaceutical company, today announced that investigational NBI-827104 did ...

EEG revealed slow background activity, irregular generalized spike–waves and polyspike–waves asynchronous with myoclonic jerks, ... The paroxysmal abnormalities were reduced on sleep EEG.

After reviewing the EEG data, the team found the brains of people with epilepsy were producing slow waves – lasting less than one second – while they were awake and taking part in the test.

Research from Columbia University and NewYork-Presbyterian suggests that brain waves associated with sleep may help predict recovery in unresponsive patients with recent brain injuries. The study, ...

Mass General Brigham researchers have developed an AI tool that analyzes brain wave activity recorded during sleep using electroencephalography (EEG), a non-invasive technique that measures ...

This latter "slow-wave sleep" typically comprises up to 20% of a good night's rest—but it won't happen under disruptive conditions, such as sleep apnea, caffeine overconsumption, insomnia, or ...

--Neurocrine Biosciences, Inc., a leading neuroscience-focused biopharmaceutical company, today announced that investigational NBI-827104 did not meet its primary endpoint in the Phase 2 STEAMBOAT ...

SAN DIEGO, Dec. 6, 2022 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX), a leading neuroscience-focused biopharmaceutical company, today announced that investigational NBI-827104 did ...

SAN DIEGO, Dec. 6, 2022 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX), a leading neuroscience-focused biopharmaceutical company, today announced that investigational NBI-827104 did ...